Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.
Sunita M C De SousaNisa SheriffChau H TranAlexander M MenziesVenessa H M TsangGeorgina V LongKatherine T T TonksPublished in: Pituitary (2018)
TSH fall ≥ 80% may be an early marker of IH. Serial TSH measurement during ipilimumab therapy may be an inexpensive tool to expedite IH diagnosis.